Showing results (101-110 of 158) with videos related to
Sort By:
Pageof 16
International Journal of Radiation Oncology, Biology, Physics|September 17, 2023
Clinical Outcomes of De Novo Versus Relapsed Early Metastatic Testicular Seminoma Treated With Contemporary Radiation TherapyDaniel B Rosen, Anushka Ghosh, Andrzej Niemierko, et al.The Lancet. Respiratory Medicine|April 19, 2021
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trialJoseph K Han, Claus Bachert, Wytske Fokkens, et al.Rheumatology (Oxford, England)|November 4, 2020
Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture modelsClaire T Deakin, Charalampia Papadopoulou, Liza J McCann, et al.NPJ Primary Care Respiratory Medicine|May 26, 2021
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPDSandeep Bansal, Martin Anderson, Antonio Anzueto, et al.ERJ Open Research|June 10, 2021
INTREPID: single- <i>versus</i> multiple-inhaler triple therapy for COPD in usual clinical practiceDavid M G Halpin, Sally Worsley, Afisi S Ismaila, et al.Urology|August 9, 2020
Three-tiered Subclassification System of High-risk Prostate Cancer in Men Managed With Radical Prostatectomy: Implications for Treatment Decision-makingNayan Lamba, Santino Butler, Brandon A Mahal, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 6, 2018
Genetic susceptibility to cerebrovascular disease: A systematic reviewChristoph J Griessenauer, Sean Farrell, Atom Sarkar, et al.Respiratory Research|May 31, 2020
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trialsGary T Ferguson, Nicola Brown, Chris Compton, et al.Journal of Asthma and Allergy|September 11, 2023
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATORTanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, et al.Allergy|August 17, 2021
From DREAM to REALITI-A and beyond: Mepolizumab for the treatment of eosinophil-driven diseasesIan D Pavord, Elisabeth H Bel, Arnaud Bourdin, et al.Pageof 16